Similarly, activating mutations in AKT1 occur in nearly 4% of Luminal [19,44], and genetic amplifications of AKT2 and PDK1 are observed in all breast cancer subtypes with a frequency of 3% and 20–38%, respectively [45,46]. Here, AKT1 is linked to breast carcinoma.